Records / Laws and rulings

In re 23andMe Holding Co.: memorandum opinion approving the sale to TTAM Research Institute (June 27, 2025) (In re 23andMe Holding Co., et al., No. 25-40976-357 (Bankr. E.D. Mo.), Memorandum Opinion, ECF No. 908 (June 27, 2025))

After Regeneron won the auction, TTAM's later $305 million bid won; the court approved the sale of the business with its customers' data over the remaining objections of five states and entered its separate sale order the same day.

Dated 17 Oct 2026Source checked 17 Oct 2026Basis: primary text

In the source's own words
“At the conclusion of the auction, the Special Committee selected Regeneron as the successful bidder, with a bid of $256 million, and TTAM as the backup bidder, with a bid of $146 million (Walper Decl. ¶ 14). After the auction had closed, TTAM submitted additional proposals, one of which included a purchase price of $305 million (Walper Decl. ¶ 16). ... The Special Committee thus selected TTAM’s $305 million bid as the winning bid (Walper Decl. ¶ 19). ... For the reasons discussed below, I will grant the Debtors’ sale motion and approve the proposed transaction.”
Also read from the same source
Figures it counts in

It is shown on its own, not counted into a figure.

In re 23andMe Holding Co.: memorandum opinion approving the sale to TTAM Research… | AIData.Broker